top of page

Coronary Artery Interventions

Contemporary CABG and PCI

24 April 2025
Prof Sean Galvin, Cardiothoracic Surgeon | Dr Sarah Fairley, Interventional Cardiologist

OVERVIEW


CERC 03 brought together cardiac surgery and cardiology to discuss current practices in CABG and PCI. Prof Sean Galvin opened with the story of CABG evolution - from the Vineberg operation and Mason Sones’ first angiogram to the modern era of arterial grafting - and how to choose the right conduit for the right patient. Dr Sarah Fairley followed with a state-of-the-art review of contemporary PCI, challenging the assumption that the angiogram alone tells you what you need to know.



Both talks shared a common thread: the importance of information. What does the vessel actually look like inside? Is the stenosis functionally significant? What will this conduit do in five years? Ten? Intravascular imaging, hemodynamic assessment, CT-FFR, and intraoperative flow measurement are all available tool to aid decision-making, but uptake is variable.

KEY LEARNING POINTS


All Clinicians


  • Coronary angiography alone is frequently misleading. Hemodynamic assessment (FFR ≤0.80; resting indices ≤0.89) tells you whether a lesion is functionally significant.

  • The decision to treat, and how to treat, CAD should be made jointly by cardiologists and surgeons with all available functional and imaging data on the table.

  • CT-FFR is rapidly emerging as a pre-procedural planning tool and may soon replace diagnostic coronary angiography for many patients.

  • Stress tests are poor diagnostic tools, particularly in women where the false-positive rate is high; findings often reflect microvascular disease rather than epicardial stenosis.



Cardiothoracic Surgeons


  • Graft patency at 10 years: LIMA to LAD ~95%, radial artery ~90%, vein graft ~60–70%.

  • Radial artery harvest requires no-touch technique, pharmacological vasodilation, pedicle graft, and correct storage. Mechanical dilation destroys the graft. Properly harvested, a radial approaches mammary patency at 10–15 years.

  • Bilateral IMA: benefit only emerges at 10–15 years; significant sternal wound risk. Reserve for patients <65–70 years without multiple risk factors (COPD, obesity, diabetes, smoking, renal failure). Skeletonisation is essential to reduce sternal wound risk and it often improves flow.

  • Radial artery is the preferred alternative to bilateral IMA in higher-risk patients – it provides arterial grafting benefit without sternal wound risk.

  • Moderate stenosis: left-sided lesions can generally be grafted safely (disease likely to progress). Right-sided moderate stenosis – consider leaving ungrafted; competitive flow accelerates native disease and graft failure.

  • Radial artery catheterisation causes intimal injury equivalent to mechanical dilation: 23% vs 2% graft failure at one month. Assess a catheterised radial carefully (ultrasound, intimal thickness) before using as a conduit.

  • Intraoperative graft assessment (transit time flow, epiaortic ultrasound) is now a guideline recommendation before closing the chest.



Cardiologists


  • Intravascular imaging should be used in virtually all complex PCI. It is a class I indication for left main, long lesions, and bifurcations. Uptake remains low (~10% in the US, ~30% in Wellington).

  • IVUS and OCT are complementary: IVUS is more user-friendly and better for CTOs and ostial lesions; OCT has higher resolution and is superior for bifurcations, restenosis mechanism, and plaque characterisation.

  • Real-time IVUS guided ostial stenting (Wellington technique): use IVUS in the circumflex to precisely position an LAD ostial stent. ~150 cases locally; now used internationally.

  • Calcium >270 degrees on OCT/IVUS must be modified before stenting. Choose modality based on lesion: ‘rota’ for balloon-uncrossable lesions; shockwave or orbital atherectomy for calcified nodules in larger vessels.

  • Restenosis must be mechanistically characterised before retreatment: neointimal hyperplasia → cutting balloon + DCB; lipid → caution (no-reflow risk); thrombus → anticoagulation + consider aspiration.

  • Drug-coated balloons are promising for restenosis, small vessels, and young patients but require adequate vessel preparation and patient selection.



Anaesthetists and ICU


  • Off-pump CABG creates a prothrombotic state from platelet activation and early graft failure risk is higher. Ensure anticoagulation and antiplatelet protocols are followed carefully.

  • Post-operative aspirin: give as soon as safely possible. Soluble/sublingual forms are useful for patients not yet extubated. In unstable or bleeding patients, clinical judgement takes precedence.

  • Post-operative DAPT: strongest evidence in patients with ACS, vein grafts, off-pump surgery, and diabetics with multi-vessel disease. Not standard for all stable CABG patients.

Prof Sean Galvin 

Prof Sean Galvin is a cardiothoracic surgeon based in Wellington. His post-fellowship training focused on surgery of the thoracic aorta,  the use of arterial conduits in coronary surgery and both general and minimally invasive thoracic surgical techniques. He is actively involved in clinical research and teaching with honorary appointments at a number of academic institutes. He is the Cardiothoracic Surgical Supervisor of Training at Wellington Hospital.


Dr Sarah Fairley 

Dr Sarah Fairley is an interventional cardiologist based in Wellington with a special interest in complex PCI and intravascular imaging. She uses intravascular imaging (IVUS and OCT) in approximately 90% of her cases and has co-developed the Wellington technique of real-time IVUS guided ostial stenting – a method that has attracted international interest. She trained in both Belfast and Wellington.

References


  • Brooks N, Jones G, Beatt K, et al. Randomised placebo controlled trial of aspirin and dipyridamole in the prevention of coronary vein graft occlusion. Br Heart J. 1985;53(2):201–7. DOI: 10.1136/hrt.53.2.201

  • Kamiya H, Akhyari P, Martens A, et al. Use of the radial artery graft after transradial catheterization: is it suitable as a bypass conduit? Ann Thorac Surg. 2003;76(5):1505–9. DOI: 10.1016/s0003-4975(03)01018-x

  • Kim J, Kang Y, Sohn S. Occurrence rate and fate of competitive flow of the left internal thoracic artery used in Y-composite grafts. JTCVS Open, 2022; 11, 116-126. DOI: 10.1016/j.xjon.2022.06.006

  • Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease (SYNTAX). N Engl J Med. 2009;360(10):961–72. DOI: 10.1056/NEJMoa0804626

  • Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes (PLATO). N Engl J Med. 2009;361(11):1045–57. DOI: 10.1056/NEJMoa0904327

  • Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention (FAME). N Engl J Med. 2009;360(3):213–24. DOI: 10.1056/NEJMoa0807611

  • Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease (ISCHEMIA). N Engl J Med. 2020;382(15):1395–1407. DOI: 10.1056/NEJMoa1915922

  • Holm NR, Andreasen LN, Walsh S, et al. OCT or angiography guidance for PCI in complex bifurcation lesions (OCTOBER). N Engl J Med. 2023;389(16):1477–1487. DOI: 10.1056/NEJMoa2307770

  • Fairley SL, et al. Real-time IVUS guided (RTIG) ostial stenting: a step-by-step guide. JACC Case Rep. 2025;31(6):106346. DOI: 10.1016/j.jaccas.2025.106346

bottom of page